Gheuens Sarah

Chief Medical Officer, Director · SEC CIK 1881190
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$1.75M
21 trades
Net flow
−$1.75M
Net selling
Total filings
51
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Apr 6, 2026 ΔOwn −3.5%

Gheuens Sarah sold $102K of AGIO, trimming their stake 4%.

−$102K
2,940 sh @ $35
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 3, 2026 ΔOwn −1.6%

Gheuens Sarah sold $34.4K of AGIO, trimming their stake 2%.

−$34.4K
1,187 sh @ $29
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 3, 2026 ΔOwn −2.3%

Gheuens Sarah sold $48.7K of AGIO, trimming their stake 2%.

−$48.7K
1,681 sh @ $29
Advertisement
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jan 2, 2026 ΔOwn −4.3%

Gheuens Sarah sold $79.4K of AGIO, trimming their stake 4%.

−$79.4K
2,932 sh @ $27
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Nov 13, 2025 ΔOwn −3.8%

Gheuens Sarah sold $107.4K of AGIO, trimming their stake 4%.

−$107.4K
2,454 sh @ $44
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Oct 29, 2025 ΔOwn −5.1%

Gheuens Sarah sold $145K of AGIO, trimming their stake 5%.

−$145K
3,302 sh @ $44
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −15%

Gheuens Sarah sold $419.8K of AGIO, trimming their stake 15%.

−$419.8K
11,067 sh @ $38
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −1.4%

Gheuens Sarah sold $32.8K of AGIO, trimming their stake 1%.

−$32.8K
847 sh @ $39
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 3, 2025 ΔOwn −6.3%

Gheuens Sarah sold $139.8K of AGIO, trimming their stake 6%.

−$139.8K
4,091 sh @ $34
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −4.9%

Gheuens Sarah sold $97.6K of AGIO, trimming their stake 5%.

−$97.6K
2,909 sh @ $34
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −2.4%

Gheuens Sarah sold $40.4K of AGIO, trimming their stake 2%.

−$40.4K
1,137 sh @ $36
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −2.3%

Gheuens Sarah sold $42.2K of AGIO, trimming their stake 2%.

−$42.2K
1,187 sh @ $36
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −3.0%

Gheuens Sarah sold $59.7K of AGIO, trimming their stake 3%.

−$59.7K
1,681 sh @ $36
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 3, 2024 ΔOwn −7.8%

Gheuens Sarah sold $162.5K of AGIO, trimming their stake 8%.

−$162.5K
3,705 sh @ $44
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −3.4%

Gheuens Sarah sold $42.1K of AGIO, trimming their stake 3%.

−$42.1K
1,293 sh @ $33
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −3.3%

Gheuens Sarah sold $43.9K of AGIO, trimming their stake 3%.

−$43.9K
1,349 sh @ $33
AGIO
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Feb 14, 2024 ΔOwn −1.9%

Gheuens Sarah sold $16.1K of AGIO, trimming their stake 2%.

−$16.1K
642 sh @ $25

Frequently asked questions

How is Gheuens Sarah's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Gheuens Sarah's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.